The University at Buffalo and Toronto Rehabilitation Institute are partnering on a $4.75 million initiative to make housing, public buildings and outdoor spaces more accessible for people with disabilities and people of all ages.
A growth-factor chain of action that prompts bone marrow stem cells to repair cardiac tissue and reverse heart failure has been identified by researchers at the University at Buffalo's Center for Research in Cardiovascular Medicine. Results of the discovery of this distinct heart repair action appear online as an article-in-press in the American Journal of Physiology-Heart Circulation Physiology.
Michael Dell, president and CEO of Dell, announced today the company is making a $15 million investment in computer equipment and services to support launch of the University at Buffalo's new Institute for Healthcare Informatics.
Biomedical researchers at the University at Buffalo have engineered adult stem cells that scientists can grow continuously in culture, a discovery that could speed development of cost-effective treatments for diseases including heart disease, diabetes, immune disorders and neurodegenerative diseases.
A $634,000 grant from the Department of Defense is allowing researchers at the University at Buffalo to investigate a trio of environmental factors and their influence on the progression of multiple sclerosis.
The University at Buffalo School of Nursing in collaboration with the Catholic Health System, Erie County Medical Center, Kaleida Health and Roswell Park Cancer Institute has received a John R. Oishei Foundation grant of $100,000 to support the start-up for the Western New York Center for Nursing Workforce and Quality (WNY CNWQ).
BUFFALO, N.Y. -- The University at Buffalo Department of Neurosurgery is ranked 7th in North America in academic impact, based on an analysis of 25 neurosurgery and neurology journals published in the September issue of the Journal of Neurosurgery.
What goes through a woman's mind when she first hears the words, "You have breast cancer"? One in eight women will hear those words at some point in their lives and yet very little research has been conducted about women's thoughts at this early stage before treatment or surgery.
Treating intensive care patients who develop life-threatening bacterial infections, or septicemia, with insulin potentially could reduce their chances of succumbing to the infection, if results of a new preliminary study can be replicated in a larger study.
Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept. 11 on "Twenty-first Century Bioscience: In Silico Methods and High-Throughput Screening," which will feature a variety of cutting-edge advances in the field developed by researchers in Western New York and throughout the US.